EKO International Corp - NeuroVasc Clinical Inc. marketing update
BURLINGTON, ON, Nov. 15, 2012 /PRNewswire/ - EKO International
Corp. (EKNL -Pinksheets) (the 'Company") - is pleased to announce
that NeuroVasc Clinical Inc. intends to utilize the services
of the iMD distribution engine to instruct health providers in the
availability and use of diabetic peripheral neuropathy (DPN)
testing units and to inform the health providers of the closest
clinics able to provide patients with recommended FREMS
treatments.
Information on the value of the iMD services can be obtained on
the website http://www.imdhealth.ca/whatwedo.html which
includes the following quote:
"Award winning iMD® helps physicians, healthcare providers and
educators quickly and effectively communicate with patients
regarding their health issues directly "At The Point of Care®".
iMD® Health terminals are supplied to physicians, medical
specialists, diabetes education centers, chronic disease clinics
and healthcare providers across Canada. The iMD Health terminals are connected
to a private bidirectional communication system where the
physicians have direct access to digital medical content and
industry information when they need it."
This service is intended to be of great benefit to patients and
to clinics that receive patients referred to them for
treatment.
The Company will shortly be providing information on locations,
including the WallMart pharmacies, where testing facilities are
available for patients suffering from DPN.
This press release contains forward-looking statements that
reflect the Company's current expectation regarding future events.
Actual events could differ materially and substantially from those
projected herein and depend on a number of factors. Certain
statements in this release, and other written or oral statements
made by EKO International ("The Company") are "forward-looking
statements" within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934. You
should not place undue reliance on forward-looking statements since
they involve known and unknown risks, uncertainties and other
factors, which are, in some cases, beyond the Company's control and
which could, and likely will, materially affect actual results,
levels of activity, performance or achievements. The Company
assumes no obligation to publicly update or revise these
forward-looking statements for any reason, or to update the reasons
actual results could differ materially from those anticipated in
these forward-looking statements, even if new information becomes
available in the future. Important factors that could cause actual
results to differ materially from the company's expectations
include, but are not limited to, those factors that are disclosed
under the heading "Risk Factors" and elsewhere in documents filed
by the company from time to time with the United States Securities
and Exchange Commission and other regulatory authorities.
SOURCE EKO INTERNATIONAL CORP.